Recent Updates
Recently added Catalysts
IRD

Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting

Key Takeaway: Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting

Full Press Release Details

Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting.
Last updated: May 6, 2024